In summary, we demonstrated that combination vaccination with tetanus toxoid and GVAX can elicit a greater anti-tumor immune response in mice compared with those of mice receiving the tetanus toxoid or TC-1/cGM-CSF vaccine alone. This evidence concerns the gene CSF2 and neoplasm.